Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Cirillo

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 22, 2008
High risk of tuberculosis in health care workers in RomaniaG Sotgiu, A S Arbore, V Cojocariu, et al.
IJTLD Open|May 13, 2026
Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strainM Schiuma, A Piubello, F Saluzzo, et al.
The European Respiratory Journal|August 11, 2007
Clinical and operational value of the extensively drug-resistant tuberculosis definitionG B Migliori, G Besozzi, E Girardi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 12, 2021
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide studyN Riccardi, L Saderi, E Borroni, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2015
Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre studyE Cambau, M Viveiros, D Machado, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 8, 2017
Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatmentM Driesen, Y Kondo, B C de Jong, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 2021
First molecular-based anti-TB drug resistance survey in EritreaA B Mesfin, Z Z Araia, H N Beyene, et al.
IJTLD Open|July 5, 2024
2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatmentM van den Boom, K Bennani, C Sismanidis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2018
Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national surveyE Pavlenko, A Barbova, A Hovhannesyan, et al.
The European Respiratory Journal|February 11, 2012
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?G B Migliori, G Sotgiu, L D'Ambrosio, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 22, 2008
High risk of tuberculosis in health care workers in RomaniaG Sotgiu, A S Arbore, V Cojocariu, et al.
IJTLD Open|May 13, 2026
Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strainM Schiuma, A Piubello, F Saluzzo, et al.
The European Respiratory Journal|August 11, 2007
Clinical and operational value of the extensively drug-resistant tuberculosis definitionG B Migliori, G Besozzi, E Girardi, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 12, 2021
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide studyN Riccardi, L Saderi, E Borroni, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2015
Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre studyE Cambau, M Viveiros, D Machado, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 8, 2017
Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatmentM Driesen, Y Kondo, B C de Jong, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 2021
First molecular-based anti-TB drug resistance survey in EritreaA B Mesfin, Z Z Araia, H N Beyene, et al.
IJTLD Open|July 5, 2024
2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatmentM van den Boom, K Bennani, C Sismanidis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2018
Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national surveyE Pavlenko, A Barbova, A Hovhannesyan, et al.
The European Respiratory Journal|February 11, 2012
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?G B Migliori, G Sotgiu, L D'Ambrosio, et al.
Pageof 7